<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39952268</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Comparison of Rubber Band Ligation and Hemorrhoidectomy in Patients With Symptomatic Hemorrhoids Grade III: A Multicenter, Open-Label, Randomized Controlled Noninferiority Trial.</ArticleTitle><Pagination><StartPage>572</StartPage><EndPage>583</EndPage><MedlinePgn>572-583</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003679</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal management strategy for grade III hemorrhoids remains a subject of ongoing debate. Hemorrhoidectomy is the criterion standard, but rubber band ligation offers a less invasive outpatient alternative. Treatment variability persists due to a lack of consensus on the preferred strategy.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To directly compare the effectiveness of rubber band ligation and hemorrhoidectomy in the treatment of grade III hemorrhoids.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Open-label, parallel-group, randomized controlled noninferiority trial.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Multicenter study across 10 Dutch hospitals from October 2019 to September 2022.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients (aged 18 years or older) with symptomatic grade III (Goligher) hemorrhoids were included in this study. Exclusion criteria included prior rectal/anal surgery, more than 1 rubber band ligation/injection within the preceding 3 years, rectal radiation, preexisting sphincter injury, IBD, medical unfitness for surgery (ASA higher than 3), pregnancy, or hypercoagulability disorders.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Randomized 1:1 to rubber band ligation or hemorrhoidectomy, with up to 2 banding sessions allowed.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Primary outcomes included 12-month health-related quality of life and recurrence rate. Secondary outcomes included complications, pain, work resumption, and patient-reported outcome measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-seven patients were randomly assigned (47 rubber band ligation vs 40 hemorrhoidectomy). Rubber band ligation was not noninferior to hemorrhoidectomy in quality-adjusted life years (-0.045; 95% CI, -0.087 to -0.004). Recurrence rate was worse in the rubber band ligation group (47.5% vs 6.1%), with an absolute risk difference of 41% (95% CI, 24%-59%). Complication rates were comparable. Pain scores after hemorrhoidectomy were higher during the first week (visual analogue scale 4 vs 1; p = 0.002). Rubber band ligation group returned to work sooner (1 vs 9 days; p = 0.021). Patient-reported hemorrhoidal symptom scores favored hemorrhoidectomy.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The primary limitation of the study was its early termination due to funding constraints, resulting in a relatively small sample size and limited statistical power. Patient recruitment was hindered by significant treatment preferences and the COVID-19 pandemic.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hemorrhoidectomy may benefit patients with grade III hemorrhoids in terms of quality of life, recurrence risk, and symptom burden, whereas rubber band ligation allows faster recovery with less pain. These findings can guide clinical decision-making. See Video Abstract .</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">NCT04621695.</AbstractText><AbstractText Label="COMPARACIN DE LA LIGADURA CON BANDA ELSTICA Y LA HEMORROIDECTOMA EN PACIENTES CON HEMORROIDES SINTOMTICAS GRADO III ENSAYO MULTICNTRICO, ABIERTO, ALEATORIZADO, CONTROLADO Y DE NO INFERIORIDAD" NlmCategory="UNASSIGNED">ANTECEDENTES:La estrategia &#xf3;ptima de tratamiento para las hemorroides grado III sigue siendo un tema de debate continuo. La hemorroidectom&#xed;a es el est&#xe1;ndar de oro, pero la ligadura con banda el&#xe1;stica ofrece una alternativa ambulatoria menos invasiva. La variabilidad del tratamiento persiste debido a la falta de consenso sobre la estrategia preferida.OBJETIVO:Comparar directamente la eficacia de la ligadura con banda el&#xe1;stica y la hemorroidectom&#xed;a en el tratamiento de las hemorroides grado III.DISE&#xd1;O:Ensayo de no inferioridad, controlado, aleatorizado, de grupos paralelos y abierto.ENTORNO CLINICO:Estudio multic&#xe9;ntrico en 10 hospitales holandeses desde octubre de 2019 hasta septiembre de 2022.PACIENTES:Pacientes (&#x2265;18 a&#xf1;os) con hemorroides sintom&#xe1;ticas grado III (Goligher). Exclusiones: cirug&#xed;a rectal/anal previa, &gt;1 ligadura con banda el&#xe1;stica/inyecci&#xf3;n en los tres a&#xf1;os anteriores, radiaci&#xf3;n rectal, lesi&#xf3;n preexistente del esf&#xed;nter, enfermedad inflamatoria intestinal, incapacidad m&#xe9;dica para la cirug&#xed;a (ASA &gt;3), embarazo o trastornos de hipercoagulabilidad.INTERVENCIONES:Aleatorizaci&#xf3;n 1:1 para ligadura con banda el&#xe1;stica o hemorroidectom&#xed;a, con hasta dos sesiones de ligadura permitidas.PRINCIPALES MEDIDAS DE RESULTADOS:Primarias: calidad de vida relacionada con la salud a los 12 meses y tasa de recurrencia. Secundarias: complicaciones, dolor, reanudaci&#xf3;n del trabajo y medidas de resultados informadas por el paciente.RESULTADOS:Se aleatorizaron ochenta y siete pacientes (47 ligadura con banda el&#xe1;stica frente a 40 hemorroidectom&#xed;a). La ligadura con banda el&#xe1;stica no fue no inferior a la hemorroidectom&#xed;a en a&#xf1;os de vida ajustados por calidad (-0,045, intervalo de confianza del 95 %: -0,087 a -0,004). La tasa de recurrencia fue peor en el grupo de ligadura con banda el&#xe1;stica (47,5 % frente a 6,1 %), con una diferencia de riesgo absoluto del 41 % (intervalo de confianza del 95 %: 24 %-59 %). Las tasas de complicaciones fueron comparables. Las puntuaciones de dolor posthemorroidectom&#xed;a fueron m&#xe1;s altas durante la primera semana (escala anal&#xf3;gica visual 4 frente a 1; p = 0,002). El grupo de ligadura con banda el&#xe1;stica volvi&#xf3; al trabajo antes (1 frente a 9 d&#xed;as; p = 0,021). Las puntuaciones de s&#xed;ntomas hemorroidales notificadas por los pacientes favorecieron a la hemorroidectom&#xed;a.LIMITACIONES:La principal limitaci&#xf3;n del estudio fue su finalizaci&#xf3;n temprana debido a las limitaciones de financiaci&#xf3;n, lo que dio lugar a un tama&#xf1;o de muestra relativamente peque&#xf1;o y a un poder estad&#xed;stico limitado. El reclutamiento de pacientes se vio obstaculizado por las preferencias significativas de tratamiento y la pandemia de COVID-19.CONCLUSIONES:La hemorroidectom&#xed;a puede beneficiar a los pacientes con hemorroides de grado III en t&#xe9;rminos de calidad de vida, riesgo de recurrencia y carga de s&#xed;ntomas, mientras que la ligadura con banda el&#xe1;stica permite una recuperaci&#xf3;n m&#xe1;s r&#xe1;pida con menos dolor. Estos hallazgos pueden orientar la toma de decisiones cl&#xed;nicas. (Traducci&#xf3;n- Dr. Francisco M. Abarca-Rendon )N&#xda;MERO DE REGISTRO DEL ENSAYO CL&#xcd;NICO:NCT04621695.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Colon and Rectal Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Oostendorp</LastName><ForeName>Justin Y</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0002-2835-3997</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Proctos Kliniek, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dekker</LastName><ForeName>Lisette</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8092-7196</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Proctos Kliniek, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Dieren</LastName><ForeName>Susan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3084-0495</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldkamp</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0002-2553-6875</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Proctos Kliniek, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bemelman</LastName><ForeName>Willem A</ForeName><Initials>WA</Initials><Identifier Source="ORCID">0000-0002-1037-9945</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han-Geurts</LastName><ForeName>Ingrid J M</ForeName><Initials>IJM</Initials><Identifier Source="ORCID">0000-0001-5058-0574</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Proctos Kliniek, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>HollAND Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04621695</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D000073843">Equivalence Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006484" MajorTopicYN="Y">Hemorrhoids</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008026" MajorTopicYN="N">Ligation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061865" MajorTopicYN="Y">Hemorrhoidectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Goligher</Keyword><Keyword MajorTopicYN="N">Grade III</Keyword><Keyword MajorTopicYN="N">Hemorrhoidectomy</Keyword><Keyword MajorTopicYN="N">Hemorrhoids</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Rubber band ligation</Keyword></KeywordList><CoiStatement><b>Financial Disclosure:</b> None reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Han-Geurts</LastName><ForeName>I J M</ForeName><Initials>IJM</Initials><AffiliationInfo><Affiliation>surgeon at the Proctos Kliniek.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bemelman</LastName><ForeName>W A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>surgeon at the Amsterdam University Medical Center (UMC).</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Oostendorp</LastName><ForeName>J Y</ForeName><Initials>JY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dekker</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baeten</LastName><ForeName>C I M</ForeName><Initials>CIM</Initials><AffiliationInfo><Affiliation>surgeon at Groene Hart Ziekenhuis.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Breukink</LastName><ForeName>S O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>surgeon at Maastricht UMC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>de Castro</LastName><ForeName>S M M</ForeName><Initials>SMM</Initials><AffiliationInfo><Affiliation>surgeon at Onze Lieve Vrouwe Gasthuis.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meij</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>surgeon at Central Military Hospital Utrecht.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Ruler</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>surgeon at Ijsselland ziekenhuis.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schiphorst</LastName><ForeName>A H W</ForeName><Initials>AHW</Initials><AffiliationInfo><Affiliation>surgeon at Diakonessenhuis.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schouten</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>surgeon at Flevoziekenhuis.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Veldkamp</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>surgeon at Proctos Kliniek.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Dieren</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>epidemiologist/statistician at Department of Surgery Amsterdam UMC.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>15</Day><Hour>15</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>14</Day><Hour>19</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39952268</ArticleId><ArticleId IdType="pmc">PMC11999089</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003679</ArticleId><ArticleId IdType="pii">00003453-990000000-00875</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Riss S, Weiser FA, Schwameis K, et al. . The prevalence of hemorrhoids in adults. Int J Colorectal Dis. 2012;27:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">21932016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielen MHK. Incidence and Prevalence Rates of Haemorrhoids in Dutch General Practice Classified by Sex in 2022 (per 1000 Patient Years). Jaarcijfers Aandoeningen - Nivel Zorgregistraties Eerste Lijn. Utrecht, The Netherlands: Nivel; 2022.</Citation></Reference><Reference><Citation>Goligher JC. Surgery of the Anus, Rectum and Colon. 3rd ed. London: Bailli&#xe8;re Tindall; 1975.</Citation></Reference><Reference><Citation>van Tol RR, Kleijnen J, Watson AJM, et al. . European Society of ColoProctology: guideline for haemorrhoidal disease. Colorectal Dis. 2020;22:650&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">32067353</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis BR, Lee-Kong SA, Migaly J, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of hemorrhoids. Dis Colon Rectum. 2018;61:284&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">29420423</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson AJ, Hudson J, Wood J, et al. ; eTHoS study group. Comparison of stapled haemorrhoidopexy with traditional excisional surgery for haemorrhoidal disease (eTHoS): a pragmatic, multicentre, randomised controlled trial. Lancet. 2016;388:2375&#x2013;2385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5269572</ArticleId><ArticleId IdType="pubmed">27726951</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam V, Thaha MA, Rabindranath KS, Campbell KL, Steele RJ, Loudon MA. Systematic review of randomized trials comparing rubber band ligation with excisional haemorrhoidectomy. Br J Surg. 2005;92:1481&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pubmed">16252313</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SR, Tiernan JP, Watson AJM, et al. ; HubBLe Study team. Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial. Lancet. 2016;388:356&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4956910</ArticleId><ArticleId IdType="pubmed">27236344</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tol RR, Bruijnen MPA, Melenhorst J, van Kuijk SMJ, Stassen LPS, Breukink SO. A national evaluation of the management practices of hemorrhoidal disease in the Netherlands. Int J Colorectal Dis. 2018;33:577&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899108</ArticleId><ArticleId IdType="pubmed">29546558</ArticleId></ArticleIdList></Reference><Reference><Citation>Altomare DF, Picciariello A, Pecorella G, et al. ; Italian Haemorrhoid Survey Group. Surgical management of haemorrhoids: an Italian survey of over 32 000 patients over 17 years. Colorectal Dis. 2018;20:1117&#x2013;1124.</Citation><ArticleIdList><ArticleId IdType="pubmed">30004171</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekker L, Han-Geurts IJM, R&#xf8;rvik HD, van Dieren S, Bemelman WA. Rubber band ligation versus haemorrhoidectomy for the treatment of grade II-III haemorrhoids: a systematic review and meta-analysis of randomised controlled trials. Tech Coloproctol. 2021;25:663&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8124052</ArticleId><ArticleId IdType="pubmed">33683503</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;2010:c332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844940</ArticleId><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekker L, Han-Geurts IJM, van Dieren S, Bemelman WA. HollAND trial: comparison of rubber band ligation and haemorrhoidectomy in patients with symptomatic haemorrhoids grade III: study protocol for a multicentre, randomised controlled trial and cost&#x2013;utility analysis. BMJ Open. 2021;11:e046836.</Citation></Reference><Reference><Citation>Milligan ETC, Naunton Morgan C, Jones L, Officer R. Surgical anatomy of the anal canal, and the operative treatment of haemorrhoids. Lancet. 1937;230:1119&#x2013;1124.</Citation></Reference><Reference><Citation>Ferguson JA, Mazier WP, Ganchrow MI, Friend WG. The closed technique of hemorrhoidectomy. Surgery. 1971;70:480&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">5568533</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol G. EuroQol&#x2014;a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiper SZ, Kimman ML, Van Tol RR, et al. . Patient reported outcome measure-haemorrhoidal impact and satisfaction score (PROM-HISS): development, reliability and construct validity. Colorectal Dis. 2022;24:992&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9544465</ArticleId><ArticleId IdType="pubmed">35119715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MJ, Morgan J, Watson AJM, Jones GL, Brown SR. A validated severity score for haemorrhoids as an essential prerequisite for future haemorrhoid trials. Tech Coloproctol. 2019;23:33&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6394714</ArticleId><ArticleId IdType="pubmed">30725242</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m PO, Qvist N, Raahave D, Lindsey I, Mortensen N; Stapled or Open Pile Procedure (STOPP) trial study group. Randomized clinical trial of symptom control after stapled anopexy or diathermy excision for haemorrhoid prolapse. Br J Surg. 2010;97:167&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">20035531</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44:77&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1760067</ArticleId><ArticleId IdType="pubmed">9862829</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Mijnsbrugge GJ, Molenaar C, Buyl R, Westert G, van der Wees PJ. How is your proctology patient really doing? Outcome measurement in proctology: development, design and validation study of the Proctoprom. Tech Coloproctol. 2020;24:291&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">32112248</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tol RR, Kimman ML, Melenhorst J, Stassen LPS, Dirksen CD, Breukink SO; Members of the Steering Group. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals. Colorectal Dis. 2019;21:570&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">30628177</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19:343&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">27325326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerjy R, Lindhoff-Larson A, Nystr&#xf6;m PO. Grade of prolapse and symptoms of haemorrhoids are poorly correlated: result of a classification algorithm in 270 patients. Colorectal Dis. 2008;10:694&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">18294262</ArticleId></ArticleIdList></Reference><Reference><Citation>Federatie Medisch Specialisten. Behandelalgoritme symptomatische hemorro&#xef;den - Richtlijn - Richtlijnendatabase. Updated July 17, 2015. Accessed January 7, 2024.</Citation></Reference><Reference><Citation>Kuiper SZ, Dirksen CD, Mitalas L, et al. . Responsiveness of the patient-reported outcome measure-haemorrhoidal impact and satisfaction score in patients with haemorrhoidal disease. Colorectal Dis. 2023;25:1832&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pubmed">37475163</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM. External validity of randomised controlled trials: &#x201c;to whom do the results of this trial apply?&#x201d; Lancet. 2005;365:82&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">15639683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bothwell LE, Greene JA, Podolsky SH, Jones DS. Assessing the gold standard&#x2014;lessons from the history of RCTs. N Engl J Med. 2016;374:2175&#x2013;2181.</Citation><ArticleIdList><ArticleId IdType="pubmed">27248626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasmann KA, Wijsman P, van Dieren S, Bemelman W, Buskens C. Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses. BMJ Open. 2019;9:e031151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6797441</ArticleId><ArticleId IdType="pubmed">31619428</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustinus S, van Goor I, Berkhof J, et al. . Alternative randomized trial designs in surgery: a systematic review. Ann Surg. 2022;276:753&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9534057</ArticleId><ArticleId IdType="pubmed">35866665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35333803</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Administration of an Anal Bulking Agent With Polyacrylate-Polyalcohol Copolymer Particles Versus Endoanal Electrical Stimulation With Biofeedback for the Management of Mild and Moderate Anal Incontinence: A Randomized Prospective Study.</ArticleTitle><Pagination><StartPage>917</StartPage><EndPage>927</EndPage><MedlinePgn>917-927</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000002458</ELocationID><Abstract><AbstractText Label="BACKGROUND">There are few treatment options for mild-to-moderate anal incontinence with isolated internal anal sphincter defects or anal incontinence without muscle damage. Less-invasive techniques are generally favored.</AbstractText><AbstractText Label="OBJECTIVE">To compare the results between the use of an anal bulking agent with polyacrylate-polyalcohol copolymer particles and endoanal electrical stimulation with biofeedback in patients with mild or moderate anal incontinence.</AbstractText><AbstractText Label="DESIGN">This was a prospective parallel-group, single-institution, randomized clinical trial.</AbstractText><AbstractText Label="SETTINGS">This study was conducted in an ambulatory setting at the Colorectal Physiology Service of the Hospital das Clinicas, Medical School, University of Sao Paulo.</AbstractText><AbstractText Label="PATIENTS">This study included patients who had anal incontinence for &gt;6 months with isolated internal anal sphincter muscle damage or absence of anatomical defects in the anorectal sphincter complex.</AbstractText><AbstractText Label="INTERVENTIONS">Anal bulking agent and endoanal electrical stimulation with biofeedback.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcome measure was the Cleveland Clinic Florida Fecal Incontinence Score, and the secondary outcome measures included quality of life, recommended procedures, and anorectal manometry.</AbstractText><AbstractText Label="RESULTS">There were no significant between-group differences in mean age, sex, BMI, stool consistency, and Cleveland Clinic Florida Fecal Incontinence Score (p = 0.20) at baseline. After 12 months, the Cleveland Clinic Florida Fecal Incontinence Score was found to be significantly improved in patients treated with the bulking agent compared to those treated with electrical stimulation (mean, 6.2 vs 9.2; p = 0.002), though the anorectal manometry parameters did not change significantly. The mean anal Cleveland Clinic Florida Fecal Incontinence Score declined by 4.2 points in the bulking agent group compared to a decline of 0.8 in the electrical stimulation group (mean difference in decline: 3.4 points; 95% CI, 1.2-5.5). Quality-of life evaluation showed similar results between groups comparing baseline parameters with 12-month follow-up.</AbstractText><AbstractText Label="LIMITATIONS">The short follow-up period of 1 year, atypical method of biofeedback, and unmatched baseline in some of the quality-of-life scales between the 2 groups limited this study.</AbstractText><AbstractText Label="CONCLUSIONS">In patients with mild or moderate anal incontinence, the Cleveland Clinic Florida Fecal Incontinence Score significantly improved in the bulking agent with polyacrylate-polyalcohol copolymer group compared with the endoanal electrical stimulation with biofeedback group. See Video Abstract at http://links.lww.com/DCR/B938.</AbstractText><AbstractText Label="ADMINISTRACIN DE UN GEL ANAL CON PARTCULAS DE COPOLMERO DE POLIACRILATOPOLIALCOHOL VERSUS ESTIMULACIN ELCTRICA ENDOANAL CON EJERCICIOS ANALES BIOFEEDBACK PARA EL MANEJO DE LA INCONTINENCIA ANAL LEVE Y MODERADA UN ESTUDI PROSPECTIVO ALEATORIZADO">ANTECEDENTES:Hasta la fecha, existen pocas opciones de tratamiento para la incontinencia anal de leve a moderada con defectos aislados del esf&#xed;nter anal interno o la incontinencia anal sin da&#xf1;o muscular. Por lo general, se prefieren t&#xe9;cnicas menos invasivas.OBJETIVO:El objetivo fue comparar los resultados entre el uso de un gel intra-anal con part&#xed;culas de copol&#xed;mero de poliacrilato-polialcohol y la estimulaci&#xf3;n el&#xe9;ctrica endoanal con ejercicios anales en pacientes con incontinencia anal leve o moderada.DISE&#xd1;O:Este fue un ensayo cl&#xed;nico aleatorio prospectivo de grupos paralelos, de una instituci&#xf3;n, realizado en cuatro etapas: base, procedimientos, postratamiento temprano y tard&#xed;o.AJUSTE:Este estudio se realiz&#xf3; en el ambulatorio de Fisiolog&#xed;a Colorrectal del Servicio de Coloproctolog&#xed;a del Hospital das Cl&#xed;nicas, Facultad de Medicina, Universidad de S&#xe3;o Paulo.PACIENTES:Paciente con incontinencia anal con m&#xe1;s de 6 meses, con da&#xf1;o muscular aislado del esf&#xed;nter anal interno o ausencia de defectos anat&#xf3;micos en el esf&#xed;nter anorrectal.INTERVENCIONES:Las intervenciones incluyeron la inyecci&#xf3;n del gel intra-anal y estimulaci&#xf3;n el&#xe9;ctrica endoanal con ejercicios anales.PRINCIPALES MEDIDAS DE RESULTADO:Indice de incontinencia fecal (Cleveland Clinic Florida), Indice de calidad de vida, los procedimientos recomendados y la manometr&#xed;a anorrectal.RESULTADOS:No hubo diferencias significativas entre los grupos en cuanto a la edad media, el sexo, el &#xed;ndice de masa corporal, la consistencia de las heces y la puntuaci&#xf3;n de incontinencia fecal (p = 0,20) al inicio del estudio. Despu&#xe9;s de 12 meses, la puntuaci&#xf3;n de incontinencia fecal mejor&#xf3; significativamente en los pacientes tratados con el el gel intra-anal (media = 6,2) en comparaci&#xf3;n con los tratados con estimulaci&#xf3;n el&#xe9;ctrica (media = 9,2; p = 0,002), aunque los par&#xe1;metros de manometr&#xed;a anorrectal no mejoraron significativamente. La puntuaci&#xf3;n anal media de incontinencia fecal disminuy&#xf3; 4,2 puntos en el grupo del Gel intra-anal en comparaci&#xf3;n con 0,8 en el grupo de estimulaci&#xf3;n el&#xe9;ctrica (diferencia media en la disminuci&#xf3;n: 3,4 puntos; IC del 95%: 1,2 a 5,5). La evaluaci&#xf3;n de la calidad de vida mostr&#xf3; resultados similares entre los grupos que compararon los par&#xe1;metros iniciales con un seguimiento de 12 meses.LIMITACIONES:Breve per&#xed;odo de seguimiento de un a&#xf1;o, m&#xe9;todos diferentes de ejercicios anales y l&#xed;nea de base sin igual en algunas de las escalas de calidad de vida entre los dos grupos.CONCLUSIONES:En pacientes con incontinencia anal leve y moderada, la puntuaci&#xf3;n de incontinencia fecal mejor&#xf3; significativamente en el grupo de gel intra-anal con copol&#xed;mero de poliacrilato-polialcohol en comparaci&#xf3;n con la estimulaci&#xf3;n el&#xe9;ctrica endoanal. Consulte Video Resumen en http://links.lww.com/DCR/B938. (Traducci&#xf3;n- Dr Leonardo Alfonso Bustamante-Lopez).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corr&#xea;a Neto</LastName><ForeName>Isaac J F</ForeName><Initials>IJF</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Rodrigo A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand&#xe3;o</LastName><ForeName>D&#xe9;bora G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batista</LastName><ForeName>Patr&#xed;cia A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bustamante-Lopez</LastName><ForeName>Leonardo A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgical Health Outcomes Consortium (SHOC), Digestive Health and Surgery Institute, AdventHealth Orlando, Orlando, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconello</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nahas</LastName><ForeName>S&#xe9;rgio C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Gastroenterology, Hospital das Cl&#xed;nicas, University of S&#xe3;o Paulo, Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001676" MajorTopicYN="N">Biofeedback, Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004558" MajorTopicYN="N">Electric Stimulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005242" MajorTopicYN="Y">Fecal Incontinence</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>17</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35333803</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000002458</ArticleId><ArticleId IdType="pii">00003453-202207000-00013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miner PB Jr. Economic and personal impact of fecal and urinary incontinence. Gastroenterology. 2004;126(suppl 1):S8&#x2013;13.</Citation></Reference><Reference><Citation>Landefeld CS, Bowers BJ, Feld AD, et al. National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med. 2008;148:449&#x2013;458.</Citation></Reference><Reference><Citation>Bordeianou L, Rockwood T, Baxter N, Lowry A, Mellgren A, Parker S. Does incontinence severity correlate with quality of life? Prospective analysis of 502 consecutive patients. Colorectal Dis. 2008;10:273&#x2013;279.</Citation></Reference><Reference><Citation>Paquette IM, Varma MG, Kaiser AM, Steele SR, Rafferty JF. The American Society of Colon and Rectal Surgeons&#x2019; clinical practice guideline for the treatment of fecal incontinence. Dis Colon Rectum. 2015;58:623&#x2013;636.</Citation></Reference><Reference><Citation>Ditah I, Devaki P, Luma HN, et al. Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005&#x2013;2010. Clin Gastroenterol Hepatol. 2014;12:636&#x2013;643.e1&#x2013;e2.</Citation></Reference><Reference><Citation>Markland AD, Goode PS, Burgio KL, et al. Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study. J Am Geriatr Soc. 2010;58:1341&#x2013;1346.</Citation></Reference><Reference><Citation>Xu X, Menees SB, Zochowski MK, Fenner DE. Economic cost of fecal incontinence. Dis Colon Rectum. 2012;55:586&#x2013;598.</Citation></Reference><Reference><Citation>Melville JL, Fan MY, Newton K, Fenner D. Fecal incontinence in US women: a population-based study. Am J Obstet Gynecol. 2005;193:2071&#x2013;2076.</Citation></Reference><Reference><Citation>Rosato G, Piccinini P, Oliveira L, Habr-Gamma A, Chwat C. Initial results of a new bulking agent for fecal incontinence: a multicenter study. Dis Colon Rectum. 2015;58:241&#x2013;246.</Citation></Reference><Reference><Citation>Tjandra JJ, Lim JF, Hiscock R, Rajendra P. Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective. Dis Colon Rectum. 2004;47:2138&#x2013;2146.</Citation></Reference><Reference><Citation>Boselli AS, Pinna F, Cecchini S, et al. Biofeedback therapy plus anal electrostimulation for fecal incontinence: prognostic factors and effects on anorectal physiology. World J Surg. 2010;34:815&#x2013;821.</Citation></Reference><Reference><Citation>Naimy N, Lindam AT, Bakka A, et al. Biofeedback vs. electrostimulation in the treatment of postdelivery anal incontinence: a randomized, clinical trial. Dis Colon Rectum. 2007;50:2040&#x2013;2046.</Citation></Reference><Reference><Citation>Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36:77&#x2013;97.</Citation></Reference><Reference><Citation>Yusuf SAI, Jorge JMN, Habr-Gama A, Kiss DR, Gama Rodrigues J. Evaluation of quality of life in anal incontinence: validation of the questionnaire FIQL (Fecal Incontinence Quality of Life) [in Portuguese]. Arq Gastroenterol. 2004;41:202&#x2013;208.</Citation></Reference><Reference><Citation>Ciconelli RM, Ferraz MB, Santos W, et al. Tradu&#xe7;&#xe3;o para l&#xed;ngua portuguesa e valida&#xe7;&#xe3;o gen&#xe9;rica de avalia&#xe7;&#xe3;o de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999;39:143&#x2013;150.</Citation></Reference><Reference><Citation>Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920&#x2013;924.</Citation></Reference><Reference><Citation>De La Luz Nieto M, Wu JM, Matthews C, Whitehead WE, Markland AD. Factors associated with fecal incontinence in a nationally representative sample of diabetic women. Int Urogynecol J. 2015;26:1483&#x2013;1488.</Citation></Reference><Reference><Citation>Neto IJFC, Pinto RA, Jorge JMN, et al. Are obese patients at an increased risk of pelvic floor dysfunction compared to non-obese patients? Obes Surg. 2017;27:1822&#x2013;1827.</Citation></Reference><Reference><Citation>Bharucha AE, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Bowel disturbances are the most important risk factors for late onset fecal incontinence: a population-based case-control study in women. Gastroenterology. 2010;139:1559&#x2013;1566.</Citation></Reference><Reference><Citation>Dehli T, Stordahl A, Vatten LJ, et al. Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol. 2013;48:302&#x2013;310.</Citation></Reference><Reference><Citation>Morris OJ, Smith S, Draganic B. Comparison of bulking agents in the treatment of fecal incontinence: a prospective randomized clinical trial. Tech Coloproctol. 2013;17:517&#x2013;523.</Citation></Reference><Reference><Citation>Hong KD, Kim JS, Ji WB, Um JW. Midterm outcomes of injectable bulking agents for fecal incontinence: a systematic review and meta-analysis. Tech Coloproctol. 2017;21:203&#x2013;210.</Citation></Reference><Reference><Citation>Deutekom M, Dobben AC, Terra MP, et al. Clinical presentation of fecal incontinence and anorectal function: what is the relationship? Am J Gastroenterol. 2007;102:351&#x2013;361.</Citation></Reference><Reference><Citation>Liberman H, Faria J, Ternent CA, Blatchford GJ, Christensen MA, Thorson AG. A prospective evaluation of the value of anorectal physiology in the management of fecal incontinence. Dis Colon Rectum. 2001;44:1567&#x2013;1574.</Citation></Reference><Reference><Citation>Zutshi M, Salcedo L, Hammel J, Hull T. Anal physiology testing in fecal incontinence: is it of any value? Int J Colorectal Dis. 2010;25:277&#x2013;282.</Citation></Reference><Reference><Citation>Turel FD, Langer S, Shek KL, Dietz HP. Medium- to long-term follow-up of obstetric anal sphincter injury. Dis Colon Rectum. 2019;62:348&#x2013;356.</Citation></Reference><Reference><Citation>Oliveira L, Jorge JMN, Yusuf SAI, Habr-Gama A, Kiss D, Cecconello I. Novos tratamentos para a incontin&#xea;ncia anal: inje&#xe7;&#xe3;o de silicone melhora a qualidade de vida em 35 pacientes incontinentes. Rev bras Coloproct. 2007;27:167&#x2013;173.</Citation></Reference><Reference><Citation>Ratto C, Parello A, Donisi L, et al. Novel bulking agent for faecal incontinence. Br J Surg. 2011;98:1644&#x2013;1652.</Citation></Reference><Reference><Citation>Davis K, Kumar D, Poloniecki J. Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence. Aliment Pharmacol Ther. 2003;18:237&#x2013;243.</Citation></Reference><Reference><Citation>Altomare DF, La Torre F, Rinaldi M, Binda GA, Pescatori M. Carbon-coated microbeads anal injection in outpatient treatment of minor fecal incontinence. Dis Colon Rectum. 2008;51:432&#x2013;435.</Citation></Reference><Reference><Citation>Mellgren A, Matzel KE, Pollack J, Hull T, Bernstein M, Graf W; Nasha Dx Study Group. Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil. 2014;26:1087&#x2013;1094.</Citation></Reference><Reference><Citation>Pescatori M, Pavesio R, Anastasio G, Daini S. Transanal electrostimulation for fecal incontinence: clinical, psychologic, and manometric prospective study. Dis Colon Rectum. 1991;34:540&#x2013;545.</Citation></Reference><Reference><Citation>Byrne CM, Solomon MJ, Young JM, Rex J, Merlino CL. Biofeedback for fecal incontinence: short-term outcomes of 513 consecutive patients and predictors of successful treatment. Dis Colon Rectum. 2007;50:417&#x2013;427.</Citation></Reference><Reference><Citation>Terra MP, Dobben AC, Berghmans B, et al. Electrical stimulation and pelvic floor muscle training with biofeedback in patients with fecal incontinence: a cohort study of 281 patients. Dis Colon Rectum. 2006;49:1149&#x2013;1159.</Citation></Reference><Reference><Citation>Markland AD, Greer WJ, Vogt A, et al. Factors impacting quality of life in women with fecal incontinence. Dis Colon Rectum. 2010;53:1148&#x2013;1154.</Citation></Reference><Reference><Citation>Meyer I, Blanchard CT, Markland AD, Gibson EG, Richter HE. Fecal incontinence symptoms and impact in older versus younger women seeking care. Dis Colon Rectum. 2019;62:733&#x2013;738.</Citation></Reference><Reference><Citation>Bordeianou LG, Anger JT, Boutros M, et al.; Members of the Pelvic Floor Disorders Consortium Working Groups On Patient-Reported Outcomes. Measuring pelvic floor disorder symptoms using patient-reported instruments: proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction. Dis Colon Rectum. 2020;63:6&#x2013;23.</Citation></Reference><Reference><Citation>Lee JT, Madoff RD, Rockwood TH. Quality-of-life measures in fecal incontinence: is validation valid? Dis Colon Rectum. 2015;58:352&#x2013;357.</Citation></Reference><Reference><Citation>Tibaek S, Dehlendorff C. Do women with pelvic floor dysfunction referred by gynaecologists and urologists at hospitals complete a pelvic floor muscle training programme? A retrospective study, 1992-2008. Int Urogynecol J. 2013;24:1361&#x2013;1369.</Citation></Reference><Reference><Citation>Bartlett L, Sloots K, Nowak M, Ho YH. Biofeedback for fecal incontinence: a randomized study comparing exercise regimens. Dis Colon Rectum. 2011;54:846&#x2013;856.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>